In this video, I break down C3 AI stock and explain why this controversial AI name continues to spark debate among investors. I walk through the merger rumors, the company’s financial reality, and the catalysts that could actually drive a turnaround. More importantly, I explain why trust, not hype,
1 extracted signal · 1 resolved · 0 still active
Rick Orford - Trading Stocks and Options For AllIndependent analyst profile- Source published
- 12 Feb 2026, 01:00 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:24 UTC

AI-generated source summary
C3.ai (AI) stock is currently trading around $10.15, with a market capitalization of $1.6 billion. The company has been experiencing significant losses and faces a lawsuit for alleged securities law violations. While growth catalysts exist, particularly in the federal sector and through partnerships, the company's ongoing financial losses and litigation create considerable uncertainty. Analysts maintain a 'Hold' rating, with a high target price of $24.00, but the stock's performance has been predominantly bearish, down 70% over the past year. Investors should exercise caution and wait for clearer signs of profitability and reduced legal risks.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Rick Orford - Trading Stocks and Options For All
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
